WEED Inc.

WEED Inc.

WEED, Inc. is an early stage holding company currently focused on the development and application of cannabis-derived compounds for the treatment of human disease.
Biotechnology
1d 5d 1m 6m 1y Max

WEED Inc. News

22 May

WEED Inc. and WEED Australia Ltd. Were Proud Sponsors of the Nimbin 2019 MardiGrass Rally

WEED Inc. and its subsidiaries WEED Australia Ltd., WEED Hong Kong Limited along with WEED Israel Cannabis Ltd. were proud sponsors of the 2019 MardiGrass Cannabis law reform rally & gathering in Nimbin...

07 Mar

WEED, Inc. Signs First-of-its-Kind Agreement on Key Cannabis-Related Intellectual Property in Israel

TUCSON, AZ / ACCESSWIRE / March 7, 2019 / WEED, Inc., (BUDZ) ("WEED") announced today that it has entered into an exclusive license and assignment agreement with Yissum, the technology transfer company...

11 Dec

WEED Inc. Completes Proprietary Cannabis Genomics Pilot Study

TUCSON, AZ / ACCESSWIRE / December 11, 2018 / WEED, Inc. (BUDZ) (the ''Company'') or (''WEED'') announced that its first of many cultivar DNA sequencing tests have been perfected and finalized. ''During...

18 Oct

WEED, Inc. Acquires WEED(R) Trademarks

TUCSON, AZ / ACCESSWIRE / October 18, 2018 / WEED, Inc. (BUDZ), a global Cannabis holding company focused on the development and application of cannabis–derived compounds for the treatment of human diseases,...

10 Sep

WEED Inc. Expands Global Footprint By Entering Israel & Australia

WEED, Inc. Forms WEED Israel (Cannabis) Ltd, WEED Australia Ltd, and Cannabis Institute of Australia... TUCSON, AZ / ACCESSWIRE / September 10, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company" ...

13 Aug

WEED, Inc. S-1 Registration Statement Declared Effective by Securities and Exchange Commission

TUCSON, AZ / ACCESSWIRE / August 13, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company" or "WEED"), a current alternative reporting public company focused on the development and application of cannabis-derived...

13 Apr

Former House Speaker John Boehner Is the New Face of Marijuana Legalization

On April 11, Bloomberg reported that Boehner joined the advisory board of Acreage Holdings, a cannabis dispensary and cultivation company. Marijuana legalization was never a popular topic among Republicans,...

12 Apr

3 Reasons Why Weed Inc Stock Could Surprise Investors

Anytime you discuss the marijuana industry, it’s bound to generate controversy. From its January peak, Weed stock has tanked an alarming 74%. While the prospects of legal marijuana are certainly exciting,...

13 Mar

WEED, Inc. Completes Purchase of Colorado Bioscience Property and Completes First Board of Directors Meetin

Subsidiary, Sangre AgroTech, Receives Commercial Redevelopment Permit for BioScience Research Center in La Veta, Colorado TUCSON, AZ / ACCESSWIRE / March 13, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company"...

13 Mar

WEED, Inc. Announces the Appointment of Dr. Patrick E. Williams to Its Board of Directors

TUCSON, AZ / ACCESSWIRE / March 13, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company," or " WEED "), fka United Mines, Inc., a current alternative reporting public company focused on ...

Load more

About WEED Inc.

Our wholly-owned subsidiary, Sangre AT, LLC, dba Sangre AgroTech (“Sangre”), has begun a five-year Cannabis Genomic Study to complete a genetic blueprint of the Cannabis plant genus, by creating a global genomic classification of the entire plant. By targeting cannabis-derived molecules that stimulate the endocannabinoid system, Sangre’s research team plans to develop scientifically-valid and evidence-based cannabis strains for the production of disease-specific medicines. The goal of the research is to identify, collect, patent, and archive a collection of highly-active medicinal strains. We plan to conduct this study only in states where cannabis has been legalized for medicinal purposes.

Team

Glenn E. Martin
President, CEO, CFO, and Director
Nicole Breen
Secretary, Treasurer, and Director
$ 0.09
20.60%
Open:
0.07
High:
0.10
Low:
0.07
Symbol:
BUDZ